We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

116 hedge funds and large institutions have $39.6M invested in Sanofi Contingent Value Rights in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 4

15% more capital invested

Capital invested by funds: $34.4M → $39.6M (+$5.12M)

6% more funds holding

Funds holding: 109 → 116 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 16

Holders
116
Holders Change
+7
Holders Change %
+6.42%
% of All Funds
3.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
16
Reduced
16
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Brigade Capital Management
New York
+$3.09M
2
NGA
New Generation Advisors
Massachusetts
+$427K
3
BHMP
Bardin Hill Management Partners
New York
+$365K
4
HCM
Highbridge Capital Management
New York
+$260K
5
SCM
Stonehill Capital Management
New York
+$127K

Top Sellers

Rank Fund Capital Flow
1
OAM
Oxford Asset Management
United Kingdom
-$1.15M
2
DAM
Deltec Asset Management
New York
-$63.3K
3
BCM
Basso Capital Management
Connecticut
-$25.3K
4
TL
TowerView LLC
New York
-$12.7K
5
CL
CSS LLC
Illinois
-$10.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
PFS
51
Prospera Financial Services
Texas
$5K +$5.07K +20,000 New
BIA
52
Biondo Investment Advisors
Pennsylvania
$4K -$209 -825 -5%
CS
53
Credit Suisse
Switzerland
$4K – – –
HK
54
Horizon Kinetics
New York
$4K – – –
ISL
55
Ingalls & Snyder LLC
New York
$4K – – –
MC
56
Moors & Cabot
Massachusetts
$4K – – –
RIL
57
Rothschild Investment LLC
Illinois
$4K – – –
RL
58
Ruffer LLP
United Kingdom
$4K – – –
RJA
59
Raymond James & Associates
Florida
$3K -$9 -35 -0.3%
BlackRock
60
BlackRock
New York
$3K – – –
DA
61
Dillon & Associates
Michigan
$3K – – –
Wolverine Trading
62
Wolverine Trading
Illinois
$3K – – –
TSS
63
Two Sigma Securities
New York
$3K +$3K +11,841 New
PNC Financial Services Group
64
PNC Financial Services Group
Pennsylvania
$2K -$588 -2,322 -19%
Bank of Montreal
65
Bank of Montreal
Ontario, Canada
$2K – – –
Deutsche Bank
66
Deutsche Bank
Germany
$2K – – –
BNP Paribas Financial Markets
67
BNP Paribas Financial Markets
France
$1.47K – – –
Royal Bank of Canada
68
Royal Bank of Canada
Ontario, Canada
$1K -$236 -933 -25%
RWA
69
Ropes Wealth Advisors
Massachusetts
$1K +$154 +607 +30%
Creative Planning
70
Creative Planning
Kansas
$1K +$646 +2,552 +150%
WEC
71
Winslow Evans & Crocker
Massachusetts
$372 – – –
SIM
72
Sonora Investment Management
Arizona
$337 – – –
SWA
73
Sutton Wealth Advisors
Florida
$91 – – –
ECM
74
Estabrook Capital Management
New York
$4 – – –
OAM
75
Oxford Asset Management
United Kingdom
– -$1.15M -4,769,550 Closed
1 2
3
4

GCVRZ Hedge Fund Activity: Q3 2016 in Review

116 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2016, worth a combined $39.6M — up 15% from $34.4M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new GCVRZ positions and 4 closed out — a net gain of 9 holders — while 16 added to existing stakes and 16 trimmed.

The largest buyer was Brigade Capital Management, opening a new position worth an estimated $3.09M. The largest seller was Oxford Asset Management, exiting entirely with an estimated $1.15M sold.

  • 116 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2016, up from 109 in Q2 2016.
  • Funds reported $39.6M of Sanofi Contingent Value Rights stock for Q3 2016, up 15% quarter-over-quarter.
  • 13 funds opened new Sanofi Contingent Value Rights positions in Q3 2016 and 4 closed out, a net change of +9 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2016 was Brigade Capital Management, an estimated $3.09M added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2016 was Oxford Asset Management, an estimated $1.15M sold.

Based on aggregated 13F filings for Q3 2016.